NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report
Background: NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efcacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants are hetero...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
SpringerOpen
2021
|